CompoundList
Sign in
Molecular formula

C16H18N6O4S

21 compounds have this formula on CompoundList.

Molar mass
390.42g/mol
Monoisotopic mass
390.1110Da
Atoms
45
Elements
5
Rings plus double bonds
11

The formula C16H18N6O4S describes a molecule made of 16 carbon atoms, 18 hydrogen atoms, 6 nitrogen atoms, 4 oxygen atoms and 1 sulfur atom. It is written in Hill notation: carbon first, then hydrogen, then the other elements in alphabetical order. The formula tells you which atoms are present, not how they are connected, which is why several different chemicals can share it.

Elemental composition

  • C Carbon × 1649.22%
    12.011 × 16 = 192.176 g/mol
  • H Hydrogen × 184.65%
    1.008 × 18 = 18.144 g/mol
  • N Nitrogen × 621.53%
    14.007 × 6 = 84.042 g/mol
  • O Oxygen × 416.39%
    15.999 × 4 = 63.996 g/mol
  • S Sulfur × 18.21%
    32.06 × 1 = 32.060 g/mol
Look up another formula

Compounds with the formula C16H18N6O4S

Isomers we list, best known first. Open one to see its structure, properties, safety data and suppliers.

Showing 1 to 21 of 21 compounds

2-[2-Amino-6-(pyridin-2-ylmethylsulfanyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol chemical structure, C16H18N6O4S, CAS 13153-28-1
2-[2-Amino-6-(pyridin-2-ylmethylsulfanyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
CAS 13153-28-1C16H18N6O4S
2-[2-Amino-6-(pyridin-3-ylmethylsulfanyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol chemical structure, C16H18N6O4S, CAS 13153-29-2
2-[2-Amino-6-(pyridin-3-ylmethylsulfanyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
CAS 13153-29-2C16H18N6O4S
N-(5-(4-(N,N-Dimethylsulfamoyl)phenyl)-1,3,4-oxadiazol-2-yl)-1-ethyl-1H-pyrazole-3-carboxamide chemical structure, C16H18N6O4S, CAS 1170644-02-6
N-(5-(4-(N,N-Dimethylsulfamoyl)phenyl)-1,3,4-oxadiazol-2-yl)-1-ethyl-1H-pyrazole-3-carboxamide
CAS 1170644-02-6C16H18N6O4S
N-[5-(1,3-Dimethyl-1H-pyrazol-5-yl)-1,3,4-oxadiazol-2-yl]-4-(dimethylsulfamoyl)benzamide chemical structure, C16H18N6O4S, CAS 1170920-73-6
N-[5-(1,3-Dimethyl-1H-pyrazol-5-yl)-1,3,4-oxadiazol-2-yl]-4-(dimethylsulfamoyl)benzamide
CAS 1170920-73-6C16H18N6O4S
4-(1,7-Dimethyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[2,1-f]purin-9(6H)-yl)benzenesulfonamide chemical structure, C16H18N6O4S, CAS 919035-12-4
4-(1,7-Dimethyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[2,1-f]purin-9(6H)-yl)benzenesulfonamide
CAS 919035-12-4C16H18N6O4S
N-[5-(1,5-Dimethyl-1H-pyrazol-3-yl)-1,3,4-oxadiazol-2-yl]-4-(dimethylsulfamoyl)benzamide chemical structure, C16H18N6O4S, CAS 1019101-52-0
N-[5-(1,5-Dimethyl-1H-pyrazol-3-yl)-1,3,4-oxadiazol-2-yl]-4-(dimethylsulfamoyl)benzamide
CAS 1019101-52-0C16H18N6O4S
1,5-Dimethyl-N-[2-methyl-4-oxo-6-propylthieno[2,3-D]pyrimidin-3(4H)-YL]-4-nitro-1H-pyrazole-3-carboxamide chemical structure, C16H18N6O4S, CAS 1005627-39-3
1,5-Dimethyl-N-[2-methyl-4-oxo-6-propylthieno[2,3-D]pyrimidin-3(4H)-YL]-4-nitro-1H-pyrazole-3-carboxamide
CAS 1005627-39-3C16H18N6O4S
1-Ethyl-N-[2-methyl-4-oxo-6-propylthieno[2,3-D]pyrimidin-3(4H)-YL]-4-nitro-1H-pyrazole-3-carboxamide chemical structure, C16H18N6O4S, CAS 1005693-91-3
1-Ethyl-N-[2-methyl-4-oxo-6-propylthieno[2,3-D]pyrimidin-3(4H)-YL]-4-nitro-1H-pyrazole-3-carboxamide
CAS 1005693-91-3C16H18N6O4S
N-(Furan-2-ylmethyl)-2-(5-methoxy-2-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-4-oxopyridin-1(4H)-yl)acetamide chemical structure, C16H18N6O4S, CAS 946343-28-8
N-(Furan-2-ylmethyl)-2-(5-methoxy-2-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-4-oxopyridin-1(4H)-yl)acetamide
CAS 946343-28-8C16H18N6O4S
Ethyl (2-{[3-(7-hydroxy-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)propanoyl]amino}-1,3-thiazol-4-yl)acetate chemical structure, C16H18N6O4S, CAS 1324087-69-5
Ethyl (2-{[3-(7-hydroxy-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)propanoyl]amino}-1,3-thiazol-4-yl)acetate
CAS 1324087-69-5C16H18N6O4S
3-(1-((1-Methyl-1H-imidazol-4-yl)sulfonyl)piperidin-4-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione chemical structure, C16H18N6O4S, CAS 2034512-69-9
3-(1-((1-Methyl-1H-imidazol-4-yl)sulfonyl)piperidin-4-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione
CAS 2034512-69-9C16H18N6O4S
4-(N,N-Dimethylsulfamoyl)-N-((3-(1-methyl-1H-pyrazol-4-yl)-1,2,4-oxadiazol-5-yl)methyl)benzamide chemical structure, C16H18N6O4S, CAS 2034383-95-2
4-(N,N-Dimethylsulfamoyl)-N-((3-(1-methyl-1H-pyrazol-4-yl)-1,2,4-oxadiazol-5-yl)methyl)benzamide
CAS 2034383-95-2C16H18N6O4S
4-Ethoxy-N-(2-(6-oxo-3-(1H-1,2,4-triazol-1-yl)pyridazin-1(6H)-yl)ethyl)benzenesulfonamide chemical structure, C16H18N6O4S, CAS 1448050-57-4
4-Ethoxy-N-(2-(6-oxo-3-(1H-1,2,4-triazol-1-yl)pyridazin-1(6H)-yl)ethyl)benzenesulfonamide
CAS 1448050-57-4C16H18N6O4S
4-(N,N-Dimethylsulfamoyl)-N-((6-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)benzamide chemical structure, C16H18N6O4S, CAS 2034550-09-7
4-(N,N-Dimethylsulfamoyl)-N-((6-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)benzamide
CAS 2034550-09-7C16H18N6O4S
4-(N,N-Dimethylsulfamoyl)-N-((8-methoxy-[1,2,4]triazolo[4,3-a]pyrazin-3-yl)methyl)benzamide chemical structure, C16H18N6O4S, CAS 2034414-59-8
4-(N,N-Dimethylsulfamoyl)-N-((8-methoxy-[1,2,4]triazolo[4,3-a]pyrazin-3-yl)methyl)benzamide
CAS 2034414-59-8C16H18N6O4S
N-(4-(N-((3-(1-Ethyl-1H-pyrazol-4-yl)-1,2,4-oxadiazol-5-yl)methyl)sulfamoyl)phenyl)acetamide chemical structure, C16H18N6O4S, CAS 2034230-21-0
N-(4-(N-((3-(1-Ethyl-1H-pyrazol-4-yl)-1,2,4-oxadiazol-5-yl)methyl)sulfamoyl)phenyl)acetamide
CAS 2034230-21-0C16H18N6O4S
Baricitinib acetic acid impurity chemical structure, C16H18N6O4S, CAS 2271228-52-3
Baricitinib acetic acid impurity
CAS 2271228-52-3C16H18N6O4S
2-(5-Amino-7-benzylsulfanyltriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol chemical structure, C16H18N6O4S, CAS 59886-05-4
2-(5-Amino-7-benzylsulfanyltriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol
CAS 59886-05-4C16H18N6O4S
2-(3-Amino-13-prop-2-enylsulfanyl-4,6,8,10,12-pentazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-8-yl)-5-(hydroxymethyl)oxolane-3,4-diol chemical structure, C16H18N6O4S, CAS 73851-45-3
2-(3-Amino-13-prop-2-enylsulfanyl-4,6,8,10,12-pentazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-8-yl)-5-(hydroxymethyl)oxolane-3,4-diol
CAS 73851-45-3C16H18N6O4S
4-(1,3-Dimethyl-2,4-dioxo-1,3,5-trihydro-6H,7H,8H-1,3-diazaperhydroino[1,2-h]p urin-9-yl)benzenesulfonamide chemical structure, C16H18N6O4S, CAS 923418-34-2
4-(1,3-Dimethyl-2,4-dioxo-1,3,5-trihydro-6H,7H,8H-1,3-diazaperhydroino[1,2-h]p urin-9-yl)benzenesulfonamide
CAS 923418-34-2C16H18N6O4S
N-((3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-5-oxotetrahydrofuran-3-yl)methyl)ethanesulfonamide chemical structure, C16H18N6O4S, CAS 2910813-43-1
N-((3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-5-oxotetrahydrofuran-3-yl)methyl)ethanesulfonamide
CAS 2910813-43-1C16H18N6O4S

Frequently asked questions

What is the molar mass of C16H18N6O4S?

The molar mass of C16H18N6O4S is 390.42 g/mol, calculated from standard atomic weights for 16 carbon atoms, 18 hydrogen atoms, 6 nitrogen atoms, 4 oxygen atoms and 1 sulfur atom. The monoisotopic mass is 390.1110 Da.

How many compounds have the formula C16H18N6O4S?

CompoundList lists 21 compounds with the molecular formula C16H18N6O4S, including 2-[2-Amino-6-(pyridin-2-ylmethylsulfanyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol, 2-[2-Amino-6-(pyridin-3-ylmethylsulfanyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol, N-(5-(4-(N,N-Dimethylsulfamoyl)phenyl)-1,3,4-oxadiazol-2-yl)-1-ethyl-1H-pyrazole-3-carboxamide. Compounds that share a formula are isomers. They contain the same atoms arranged differently, so their properties, uses and prices can be very different.

What is the degree of unsaturation of C16H18N6O4S?

C16H18N6O4S has a degree of unsaturation of 11. That is the total number of rings and pi bonds (a double bond counts as one, a triple bond as two) in any structure with this formula.